Handelsbanken Fonder’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,300
| Closed | -$200K | – | 1567 |
|
|
2022
Q4 | $200K | Hold |
4,300
| – | – | ﹤0.01% | 1439 |
|
|
2022
Q3 | $223K | Hold |
4,300
| – | – | ﹤0.01% | 1399 |
|
|
2022
Q2 | $203K | Hold |
4,300
| – | – | ﹤0.01% | 1494 |
|
|
2022
Q1 | $306K | Sell |
4,300
-2,200
| -34% | -$157K | ﹤0.01% | 1509 |
|
|
2021
Q4 | $486K | Sell |
6,500
-600
| -8% | -$44.9K | ﹤0.01% | 1369 |
|
|
2021
Q3 | $403K | Buy |
7,100
+1,600
| +29% | +$90.8K | ﹤0.01% | 1478 |
|
|
2021
Q2 | $242K | Buy |
+5,500
| New | +$242K | ﹤0.01% | 1672 |
|